HOME   |    PDF   |   


Title

Molecular docking analysis of novel quercetin derivatives for combating SARS-CoV-2

 

Authors

Rageh K. Hussein*, Mohammad Marashdeh & Ahmed M. El-Khayatt

 

Affiliation

Department of Physics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia; *Corresponding author

 

Email

Rageh K. Hussein - E-mail: rahussein@imamu.edu.sa

Mohammad Marashdeh -E-mail: mwmarashdeh@imamu.edu.sa

Ahmed M. El-Khayatt - E-mail: AMElhayatt@imamu.edu.sa

 

Article Type

Research Article

 

Date

Received February 1, 2023; Revised February 28, 2023; Accepted February 28, 2023, Published February 28, 2023

 

Abstract

Quercetin belongs to the flavonoid family, which is one of the most frequent types of plant phenolics. This flavonoid compound is a natural substance having a number of pharmacological effects, including anticancer and antioxidant capabilities, as well as being a strong inhibitor of various toxicologically important enzymes. We discuss the potential of newly recently synthesized quercetin-based derivatives to inhibit SARS-CoV-2 protein. ADMET analysis indicated that all of the studied compounds had low toxicities and good absorption and solubility properties. The molecular docking results revealed that the propensity for binding to SARS-CoV-2 main protease is extraordinary. The results are remarkable not only for the binding energy values, which outperform several compounds in prior studies, but also for the number of hydrogen bonds formed. Compound 7a was capable of forming 10 strong hydrogen bonds as well as interact to the protein receptor with a binding energy of -7.79 kcal/mol. Therefore, these compounds should be highlighted in further experimental studies in the context of treating SARS-CoV-2 infection and its effects.

 

Keywords

Quercetin-based derivatives; SARS-CoV-2; ADMET prediction, molecular docking.

 

Citation

      Hussein et al. Bioinformation 19(2): 178-183 (2023)

 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.